Tacrolimus Dose Requirements in African-American and Caucasian Kidney Transplant Recipients On Mycophenolate and Prednisone.

被引:0
|
作者
Beermann, K. [1 ]
Ellis, M. [1 ]
Sudan, D. [1 ]
Harris, M. [1 ]
机构
[1] Duke Hosp, Durham, NC USA
关键词
D O I
10.1097/00007890-201407151-02827
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B1200
引用
收藏
页码:827 / 828
页数:2
相关论文
共 50 条
  • [31] Comparable renal graft survival in African-American and Caucasian recipients
    Mohammed Ilyas
    Judith D. Ammons
    A. Osama Gaber
    Shane Roy III.
    Donald L. Batisky
    Russell W. Chesney
    Deborah P. Jones
    Robert J. Wyatt
    Pediatric Nephrology, 1998, 12 : 534 - 539
  • [32] Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus
    Hricik, DE
    Knauss, TC
    Bodziak, KA
    Weigel, K
    Rodriguez, V
    Seaman, D
    Siegel, C
    Valente, J
    Ak, JAS
    TRANSPLANTATION, 2003, 76 (06) : 938 - 942
  • [33] A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients - An interim report
    Jain, AB
    Hamad, I
    Rakela, J
    Dodson, F
    Kramer, D
    Demetris, J
    McMichael, J
    Starzl, TE
    Fung, JJ
    TRANSPLANTATION, 1998, 66 (10) : 1395 - 1398
  • [34] Tacrolimus Dose Variability, CYP3A5 Genotype, and Acute Rejection in African American and European American Kidney Transplant Recipients
    Seibert, S.
    Schladt, D.
    Wu, B.
    Guan, W.
    Dorr, C.
    Berglund, D.
    Remmel, R.
    Matas, A.
    Mannon, R.
    Israni, A.
    Oetting, W.
    Jacobson, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 732 - 732
  • [35] Dosing Requirements Of Astagraf Xl In African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus (aaaktrs)
    Fleming, J. N.
    Posadas-Salas, M. A.
    Taber, D. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 688 - 689
  • [36] Comparison of 12-Month Outcomes of SGLT2 Inhibitors Between African-American and Caucasian Diabetic Kidney Transplant Recipients
    Brown, A.
    Christensen, J.
    Winstead, R.
    Song, C.
    Yancey, L.
    Yakubu, I.
    Azhar, A.
    Gupta, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S992 - S993
  • [37] POSTTRANSPLANT DIABETES-MELLITUS AND METHYLPREDNISOLONE PHARMACOKINETICS IN AFRICAN-AMERICAN AND CAUCASIAN RENAL-TRANSPLANT RECIPIENTS
    TORNATORE, KM
    BIOCEVICH, DM
    REED, KA
    TOUSLEY, K
    GRAY, V
    SINGH, JP
    MURRAY, BM
    VENUTO, RC
    CLINICAL TRANSPLANTATION, 1995, 9 (04) : 289 - 296
  • [38] Alemtuzumab Induction with Steroid-Free Maintenance in African-American Kidney Transplant Recipients
    Africa, J.
    Tucker, M. J.
    Orquiza, M.
    Ghasemian, S.
    Light, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 209 - 209
  • [39] Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients
    Taber, David J.
    McGillicuddy, John W.
    Bratton, Charles F.
    Rohan, Vinayak S.
    Nadig, Satish
    Dubay, Derek
    Baliga, Prabhakar K.
    ANNALS OF SURGERY, 2017, 266 (03) : 450 - 456
  • [40] The Impact of Non-Adherence on Disparities in African-American Kidney Transplant Recipients.
    Taber, D.
    Chokkalingam, A.
    Posadas, A.
    Browning, R.
    Salazar, N.
    Kamel, M.
    Pullalarevu, R.
    Kadri, B.
    Srinivas, T.
    Chavin, K.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 518 - 519